The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Self-citationDeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Self-citationMajounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210
Self-citationMackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
Haeusler, A. R., Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M.-S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., et al. (2014) · Nature · doi:10.1038/nature13124 · Cited by 978
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740
Self-citationTargeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M. T., Jones, M., Gerhard, A., Davidson, Y. S., Robinson, A., et al. (2012) · Brain · doi:10.1093/brain/awr355 · Cited by 523
Farg, M. A., Sundaramoorthy, V., Sultana, J. M., Yang, S., Atkinson, R. A. K., Levina, V., Halloran, M. A., Gleeson, P. A., Blair, I. P., Soo, K. Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu068 · Cited by 478
Research works printed but not linked: 117
- Gijselinck, 2012, A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study, Lancet Neurol, 11, 54, 10.1016/S1474-4422(11)70261-7 · DOI · Paper page
- van der Zee, 2013, A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats, Hum Mutat, 34, 363, 10.1002/humu.22244 · DOI · Paper page
- Ash, 2013, Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS, Neuron, 77, 639, 10.1016/j.neuron.2013.02.004 · DOI · Paper page
- Mori, 2013, The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS, Science, 339, 1335, 10.1126/science.1232927 · DOI · Paper page
- Gendron, 2014, Mechanisms of toxicity in C9FTLD/ALS, Acta Neuropathol, 127, 359, 10.1007/s00401-013-1237-z · DOI
- Jones, 2013, Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat, Neurobiol Aging, 34, 2234.e1, 10.1016/j.neurobiolaging.2013.03.003 · DOI
- van Blitterswijk, 2013, Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study, Lancet Neurol, 12, 978, 10.1016/S1474-4422(13)70210-2 · DOI · Paper page
- Fratta, 2015, Screening a UK amyoytrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion, Neurobiol Aging, 36, 546.e1, 10.1016/j.neurobiolaging.2014.07.037 · DOI
- Dobson-Stone, 2013, C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients, PLoS One, 8, e56899, 10.1371/journal.pone.0056899 · DOI
- Buchman, 2013, Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation, Mol Neurodegener, 8, 12, 10.1186/1750-1326-8-12 · DOI
- Dols-Icardo, 2014, Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia, Hum Mol Genet, 23, 749, 10.1093/hmg/ddt460 · DOI
- Gómez-Tortosa, 2013, C9ORF72 hexanucleotide expansions of 20–22 repeats are associated with frontotemporal deterioration, Neurology, 80, 366, 10.1212/WNL.0b013e31827f08ea · DOI
- Byrne, 2014, Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis, Amyotroph Lateral Scler Frontotemporal Degener, 15, 148, 10.3109/21678421.2013.838586 · DOI
- Simón-Sánchez, 2012, The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions, Brain, 135, 723, 10.1093/brain/awr353 · DOI · Paper page
- Akimoto, 2014, A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories, J Med Genet, 51, 419, 10.1136/jmedgenet-2014-102360 · DOI
- Pliner, 2014, Searching for Grendel: origin and global spread of the C9ORF72 repeat expansion, Acta Neuropathol, 127, 391, 10.1007/s00401-014-1250-x · DOI
- Mok, 2012, High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients, Neurobiol Aging, 33, 1851.e1, 10.1016/j.neurobiolaging.2012.02.021 · DOI
- Jiao, 2014, Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China, Neurobiol Aging, 35, 936.e19, 10.1016/j.neurobiolaging.2013.10.001 · DOI
- Heutink, 2014, C9orf72; abnormal RNA expression is the key, Exp Neurol, 262, 102, 10.1016/j.expneurol.2014.05.020 · DOI
- Woollacott, 2014, The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues, Acta Neuropathol, 127, 319, 10.1007/s00401-014-1253-7 · DOI
- Norio, 2003, Finnish Disease Heritage I: characteristics, causes, background, Hum Genet, 112, 441, 10.1007/s00439-002-0875-3 · DOI · Paper page
- Norio, 2003, Finnish Disease Heritage II: population prehistory and genetic roots of Finns, Hum Genet, 112, 457, 10.1007/s00439-002-0876-2 · DOI
- Norio, 2003, The Finnish Disease Heritage III: the individual diseases, Hum Genet, 112, 470, 10.1007/s00439-002-0877-1 · DOI
- Hsiung, 2012, Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p, Brain, 135, 709, 10.1093/brain/awr354 · DOI · Paper page
- Mahoney, 2012, Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features, Brain, 135, 736, 10.1093/brain/awr361 · DOI · Paper page
- Dobson-Stone, 2012, C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts, Neurology, 79, 995, 10.1212/WNL.0b013e3182684634 · DOI
- Sha, 2012, Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features, Neurology, 79, 1002, 10.1212/WNL.0b013e318268452e · DOI · Paper page
- Devenney, 2014, Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile, JAMA Neurol, 71, 331, 10.1001/jamaneurol.2013.6002 · DOI · Paper page
- Englund, 2012, Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion, Neurobiol Aging, 33, 1850.e13, 10.1016/j.neurobiolaging.2012.02.019 · DOI
- Boeve, 2012, Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72, Brain, 135, 765, 10.1093/brain/aws004 · DOI · Paper page
- Chiò, 2012, Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72, Brain, 135, 784, 10.1093/brain/awr366 · DOI · Paper page
- Cooper-Knock, 2012, Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72, Brain, 135, 751, 10.1093/brain/awr365 · DOI · Paper page
- Byrne, 2012, Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study, Lancet Neurol, 11, 232, 10.1016/S1474-4422(12)70014-5 · DOI · Paper page
- Stewart, 2012, Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p, Acta Neuropathol, 123, 409, 10.1007/s00401-011-0937-5 · DOI
- Coon, 2013, Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion, Amyotroph Lateral Scler Frontotemporal Degener, 14, 132, 10.3109/17482968.2012.724075 · DOI
- Montuschi, 2015, Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy, J Neurol Neurosurg Psychiatry, 86, 168, 10.1136/jnnp-2013-307223 · DOI · Paper page
- Kertesz, 2013, Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort, Cogn Behav Neurol, 26, 146, 10.1097/WNN.0000000000000008 · DOI
- Galimberti, 2013, Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation, Biol Psychiatry, 74, 384, 10.1016/j.biopsych.2013.01.031 · DOI
- Arighi, 2012, Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations, J Alzheimers Dis, 31, 447, 10.3233/JAD-2012-120523 · DOI
- Calvo, 2012, Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene, J Neurol, 259, 2723, 10.1007/s00415-012-6640-1 · DOI
- Galimberti, 2014, The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia, Neurobiol Aging, 35, 1214.e7, 10.1016/j.neurobiolaging.2013.12.004 · DOI · Paper page
- Galimberti, 2014, C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder, Bipolar Disord, 16, 448, 10.1111/bdi.12169 · DOI · Paper page
- Meisler, 2013, C9ORF72 expansion in a family with bipolar disorder, Bipolar Disord, 15, 326, 10.1111/bdi.12063 · DOI
- Bieniek, 2014, Expanded C9ORF72 hexanucleotide repeat in depressive pseudodementia, JAMA Neurol, 71, 775, 10.1001/jamaneurol.2013.6368 · DOI
- Wojtas, 2012, C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic, Am J Neurodegener Dis, 1, 107
- Murray, 2013, Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72, Acta Neuropathol, 126, 545, 10.1007/s00401-013-1161-2 · DOI
- Pletnikova, 2014, Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion, Neurobiol Aging, 35, 2419.e17, 10.1016/j.neurobiolaging.2014.04.009 · DOI
- Irish, 2013, Neural substrates of episodic memory dysfunction in behavioural variant frontotemporal dementia with and without C9ORF72 expansions, Neuroimage Clin, 2, 836, 10.1016/j.nicl.2013.06.005 · DOI
- Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
- Van Langenhove, 2013, Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort, JAMA Neurol, 70, 365, 10.1001/2013.jamaneurol.181 · DOI
- Saint-Aubert, 2014, A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding, J Alzheimers Dis, 42, 413, 10.3233/JAD-140222 · doi:10.3233/jad-140222
- Millecamps, 2012, Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes, J Med Genet, 49, 258, 10.1136/jmedgenet-2011-100699 · DOI · Paper page
- van Rheenen, 2012, Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases, Neurology, 79, 878, 10.1212/WNL.0b013e3182661d14 · DOI
- Snowden, 2013, Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72, Amyotroph Lateral Scler Frontotemporal Degener, 14, 172, 10.3109/21678421.2013.765485 · DOI
- Siuda, 2014, Parkinsonian syndrome in familial frontotemporal dementia, Parkinsonism Relat Disord, 20, 957, 10.1016/j.parkreldis.2014.06.004 · DOI · Paper page
- Lesage, 2013, C9orf72 repeat expansions are a rare genetic cause of parkinsonism, Brain, 136, 385, 10.1093/brain/aws357 · DOI · Paper page
- Origone, 2013, Enlarging the clinical spectrum associated with C9orf 72 repeat expansions: findings in an Italian cohort of patients with parkinsonian syndromes and relevance for genetic counselling, Amyotroph Lateral Scler Frontotemporal Degener, 14, 479, 10.3109/21678421.2013.774020 · DOI
- Cooper-Knock, 2013, C9ORF72 expansions, parkinsonism, and Parkinson disease: a clinicopathologic study, Neurology, 81, 808, 10.1212/WNL.0b013e3182a2cc38 · DOI
- Nuytemans, 2013, C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease, Ann Hum Genet, 77, 351, 10.1111/ahg.12033 · DOI
- Robinson, 2014, C9ORF72 in Dementia with Lewy bodies, J Neurol Neurosurg Psychiatry, 85, 1435, 10.1136/jnnp-2014-307622 · DOI
- Goldman, 2014, Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72, JAMA Neurol, 71, 771, 10.1001/jamaneurol.2013.5762 · DOI
- Khan, 2012, Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion, J Neurol Neurosurg Psychiatry, 83, 358, 10.1136/jnnp-2011-301883 · DOI · Paper page
- Suhonen, 2014, Slowly progressive frontotemporal lobar degeneration caused by the C9ORF72 repeat expansion: a 20-year follow-up study, Neurocase, 21, 85, 10.1080/13554794.2013.873057 · DOI
- Gómez-Tortosa, 2014, Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion, Alzheimers Dement, 10, 284, 10.1016/j.jalz.2013.09.013 · DOI
- Gallagher, 2014, TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions, Acta Neuropathol, 127, 407, 10.1007/s00401-013-1239-x · DOI
- van Blitterswijk, 2014, TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia, Acta Neuropathol, 127, 397, 10.1007/s00401-013-1240-4 · DOI
- van Blitterswijk, 2014, Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers, Neurobiol Aging, 35, 2421.e13, 10.1016/j.neurobiolaging.2014.04.016 · DOI
- Fong, 2012, Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion, Alzheimers Res Ther, 4, 27, 10.1186/alzrt130 · DOI
- Chiò, 2014, Genetic counselling in ALS: facts, uncertainties and clinical suggestions, J Neurol Neurosurg Psychiatry, 85, 478, 10.1136/jnnp-2013-305546 · DOI
- van Blitterswijk, 2013, C9ORF72 repeat expansions in cases with previously identified pathogenic mutations, Neurology, 81, 1332, 10.1212/WNL.0b013e3182a8250c · DOI
- Chiò, 2012, ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations, J Neurol Neurosurg Psychiatry, 83, 730, 10.1136/jnnp-2012-302219 · DOI
- Kaivorinne, 2014, Novel TARDBP sequence variant and C9ORF72 repeat expansion in a family with frontotemporal dementia, Alzheimer Dis Assoc Disord, 28, 190, 10.1097/WAD.0b013e318266fae5 · DOI
- King, 2013, Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant, Acta Neuropathol, 125, 303, 10.1007/s00401-012-1050-0 · DOI
- Lashley, 2014, A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia, Neuropathol Appl Neurobiol, 40, 502, 10.1111/nan.12100 · DOI
- Mignarri, 2014, Double trouble? Progranulin mutation and C9ORF72 repeat expansion in a case of primary non-fluent aphasia, J Neurol Sci, 341, 176, 10.1016/j.jns.2014.03.030 · DOI
- Whitwell, 2012, Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics, Brain, 135, 794, 10.1093/brain/aws001 · DOI · Paper page
- Irwin, 2013, Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 84, 163, 10.1136/jnnp-2012-303507 · DOI
- Bede, 2013, Basal ganglia involvement in amyotrophic lateral sclerosis, Neurology, 81, 2107, 10.1212/01.wnl.0000437313.80913.2c · DOI · Paper page
- Rohrer, 2015, Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the GENFI study: cross-sectional analysis of baseline data, Lancet Neurol, 10.1016/S1474-4422(14)70324-2 · DOI · Paper page
- Bede, 2013, Multiparametric MRI study of ALS stratified for the C9orf72 genotype, Neurology, 81, 361, 10.1212/WNL.0b013e31829c5eee · DOI · Paper page
- Adeli, 2014, The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome, Neurocase, 20, 110, 10.1080/13554794.2012.732090 · DOI
- Cistaro, 2014, The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients, Eur J Nucl Med Mol Imaging, 41, 844, 10.1007/s00259-013-2667-5 · DOI · Paper page
- Chester, 2013, Rapidly progressive frontotemporal dementia and bulbar amyotrophic lateral sclerosis in Portuguese patients with C9orf72 mutation, Amyotroph Lateral Scler Frontotemporal Degener, 14, 70, 10.3109/17482968.2012.690418 · DOI
- Williams, 2013, Pathophysiological insights into ALS with C9ORF72 expansions, J Neurol Neurosurg Psychiatry, 84, 931, 10.1136/jnnp-2012-304529 · DOI
- Downey, 2012, Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion, Alzheimers Res Ther, 4, 42, 10.1186/alzrt145 · DOI
- Downey, 2014, Altered body schema processing in frontotemporal dementia with C9ORF72 mutations, J Neurol Neurosurg Psychiatry, 85, 1016, 10.1136/jnnp-2013-306995 · DOI · Paper page
- Mackenzie, 2011, A harmonized classification system for FTLD-TDP pathology, Acta Neuropathol, 122, 111, 10.1007/s00401-011-0845-8 · DOI · Paper page
- Murray, 2011, Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72, Acta Neuropathol, 122, 673, 10.1007/s00401-011-0907-y · DOI · Paper page
- Fratta, 2013, Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia, Acta Neuropathol, 126, 401, 10.1007/s00401-013-1147-0 · DOI
- Josephs, 2013, Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia, Brain, 136, 455, 10.1093/brain/aws324 · DOI
- Mori, 2013, hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations, Acta Neuropathol, 125, 413, 10.1007/s00401-013-1088-7 · DOI · Paper page
- Gendron, 2013, Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS, Acta Neuropathol, 126, 829, 10.1007/s00401-013-1192-8 · DOI · Paper page
- Mori, 2013, Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins, Acta Neuropathol, 126, 881, 10.1007/s00401-013-1189-3 · DOI · Paper page
- Davidson, 2014, Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72, Acta Neuropathol Commun, 2, 70, 10.1186/2051-5960-2-70 · DOI
- Belzil, 2013, Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood, Acta Neuropathol, 126, 895, 10.1007/s00401-013-1199-1 · DOI · Paper page
- Donnelly, 2013, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention, Neuron, 80, 415, 10.1016/j.neuron.2013.10.015 · DOI · Paper page
- Xi, 2013, Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion, Am J Hum Genet, 92, 981, 10.1016/j.ajhg.2013.04.017 · DOI · Paper page
- Belzil, 2014, Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients, Brain Res, 1584, 15, 10.1016/j.brainres.2014.02.015 · DOI
- Levine, 2013, The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs, Bioinformatics, 29, 499, 10.1093/bioinformatics/bts725 · DOI · Paper page
- Zhang, 2012, Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease, Front Genet, 3, 283, 10.3389/fgene.2012.00283 · DOI · Paper page
- Therrien, 2013, Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans, PLoS One, 8, e83450, 10.1371/journal.pone.0083450 · DOI · Paper page
- Lagier-Tourenne, 2013, Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration, Proc Natl Acad Sci USA, 110, E4530, 10.1073/pnas.1318835110 · DOI · Paper page
- Fratta, 2012, C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes, Sci Rep, 2, 1016, 10.1038/srep01016 · DOI · Paper page
- Reddy, 2013, The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures, J Biol Chem, 288, 9860, 10.1074/jbc.C113.452532 · DOI · Paper page
- Zamiri, 2014, TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins, J Biol Chem, 289, 4653, 10.1074/jbc.C113.502336 · DOI · Paper page
- Mizielinska, 2013, C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci, Acta Neuropathol, 126, 845, 10.1007/s00401-013-1200-z · DOI · Paper page
- Zu, 2013, RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia, Proc Natl Acad Sci USA, 110, E4968, 10.1073/pnas.1315438110 · DOI · Paper page
- Cooper-Knock, 2014, Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions, Brain, 137, 2040, 10.1093/brain/awu120 · DOI · Paper page
- Lee, 2013, Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic, Cell Reports, 5, 1178, 10.1016/j.celrep.2013.10.049 · DOI · Paper page
- Stepto, 2014, Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia, Acta Neuropathol, 127, 377, 10.1007/s00401-013-1235-1 · DOI
- Xu, 2013, Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration, Proc Natl Acad Sci USA, 110, 7778, 10.1073/pnas.1219643110 · DOI · Paper page
- May, 2014, C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration, Acta Neuropathol, 128, 485, 10.1007/s00401-014-1329-4 · DOI · Paper page
- Zhang, 2014, Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress, Acta Neuropathol, 128, 505, 10.1007/s00401-014-1336-5 · DOI · Paper page
- Kwon, 2014, Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells, Science, 345, 1139, 10.1126/science.1254917 · DOI · Paper page
- Su, 2014, Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS, Neuron, 83, 1043, 10.1016/j.neuron.2014.07.041 · DOI · Paper page
- Rohrer, 2013, Presymptomatic studies in genetic frontotemporal dementia, Rev Neurol (Paris), 169, 820, 10.1016/j.neurol.2013.07.010 · DOI
- Sha, 2012, Treatment implications of C9ORF72, Alzheimers Res Ther, 4, 46, 10.1186/alzrt149 · DOI
Cited by
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
C9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
Self-citationYoung, A. L., Marinescu, R. V., Oxtoby, N. P., Bocchetta, M., Yong, K., Firth, N. C., Cash, D. M., Thomas, D. L., Dick, K. M., Cardoso, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05892-0 · Cited by 596
Self-citationALS Genetics: Gains, Losses, and Implications for Future Therapies
Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370
Ducharme, S., Dols, A., Laforce, R., Devenney, E., Kumfor, F., van den Stock, J., Dallaire-Théroux, C., Seelaar, H., Gossink, F., Vijverberg, E., et al. (2020) · Brain · doi:10.1093/brain/awaa018 · Cited by 320
Metadata
- Authors
- Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K., Fratta, P., Orrell, R. W., Hardy, J., Holton, J., Revesz, T., Rossor, M. N., & Warren, J. D.
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 14
- Issue
- 3
- Pages
- 291-301
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2149444716
- Cited by
- 234
- References
- 24
- FWCI
- 26.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Wellcome Trust Senior Clinical Fellowship (091673/Z/10/Z)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. https://app.cochat.ai/papers/10.1016/s1474-4422(14)70233-9
- The paper
- Rohrer, J. D., Isaacs, A. M., Mizielinska, S., Mead, S., Lashley, T., Wray, S., Sidle, K., Fratta, P., Orrell, R. W., Hardy, J., Holton, J., Revesz, T., Rossor, M. N., & Warren, J. D. (2015). C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(14)70233-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.